What are your feelings regarding M118 after today’s conference call?
My view of the M118 program is unchanged—see #msg-57621347. I hope I’m wrong, of course.
It’s now been 17 months since MNTA announced results of the phase-2 EMINENCE study (#msg-41846746). Drugs with large commercial potential rarely if ever lie fallow for that long.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”